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ABSTRACT
EFFECTS OF BUTYLPARABEN EXPOSURE ON PANCREATC DEVELOPMENT
IN ZEBRAFISH (Danio rerio) EMBRYOS
SEPTEMBER 2016
SARAH E. BROWN, B.S., SAINT MICHAEL’S COLLEGE
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Alicia R. Timme-Laragy
Butylparaben (Butyl p-hydroxybenzoic acid) is a widely used cosmetic and
pharmaceutical preservative that has been recently shown to induce oxidative stress and
have endocrine disrupting effects in rodents, and promote adipocyte conversion of human
adipose cells. Embryonic development is extremely sensitive to oxidative stress due to
changes in cell growth, development and differentiation that occur during this life stage.
Fluctuations in redox potentials play critical roles in normal embryonic development by
guiding these cell signaling, cell-fate decisions and apoptosis. The most prevalent
endogenous antioxidant that defends against oxidative stress is glutathione (GSH), which
scavenges reactive oxygen species. The low antioxidant capacity of pancreatic beta cells
suggests that they are sensitive target tissues of oxidative stress; this has yet to be
investigated during embryonic development. Here, we aim to 1) determine whether
embryonic exposure to butylparaben prompts structural and functional changes in the
developing endocrine pancreas and 2) determine whether oxidative stress may be
involved. Transgenic insulin-GFP zebrafish embryos were treated daily with 250, 500,
1,000 and 3,000 nM butylparaben starting at 3 hours post fertilization (hpf). Pancreatic
islet and whole embryo morphological development were examined daily until 7 days
post fertilization (dpf). Redox potentials were measured at 24 and 28 hpf using HPLC.
v

Area of the pancreatic islet increased over time with increasing butylparaben exposure in
a dose-dependent manner by as much as a 55% increase in islet area at 3 dpf when
compared to controls. Butylparaben concentrations of 500 and 1,000 nM increased GSH
by 10 and 40%, respectively, and decreased oxidized glutathione disulfide by 37 and
59%. GSH redox potentials were only significant in embryos collected at 28 hpf and
became more reduced with 500 and 1,000 nM butylparaben exposure, decreasing redox
potentials by 7 and 18 mV, respectively. Cysteine redox potentials also became more
reduced, decreasing by 17 and 28 mV. Our data show that butylparaben-induced redox
potential disruptions that may be responsible for the effects on pancreatic islet structure
and function, but further studies are needed to determine how and if that directly affects
pancreas development.
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CHAPTER 1
INTRODUCTION
1.1. Diabetes
Over the past few decades, the incidence of diabetes has been rapidly increasing
worldwide. According to the Centers for Disease Control, in the United States alone, the
prevalence of diagnosed diabetes has increased 176% from 1980 to 2011. Type 2 diabetes
(T2D) is currently the seventh leading cause of death in the United States (Pitkaniemi, et
al 2004). Diabetes has often been characterized as a disease that affects the populations
of developed countries, resulting from a sedentary lifestyle. However, according to the
International Diabetes Federation, today four out of five people with diabetes now live in
developing countries. According to the World Health Organization, people in developing
countries are also exposed to greater amounts of environmental pollutants. This increased
prevalence of T2D diabetes in genetically stable populations indicates the presence of a
strong environmental component that is influencing this escalation (Pitkaniemi et al
2004). T2D develops from impaired insulin signaling that leads to the pancreas’s inability
to maintain normal glucose homeostasis, and compensate for the body’s resistance to
insulin. This compensation often fails due to mitochondrial dysfunction and endoplasmic
reticular stress, leading to beta cell apoptosis (Makaji et al 2011). Developmental
exposures to environmental factors may affect the development of the pancreas,
predisposing individuals to T2D later in life.
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1.2. The Pancreas
The pancreas is an endoderm-derived organ that consists of both exocrine and
endocrine tissues. The exocrine acinar tissues are mainly responsible for producing
digestive enzymes, whereas the endocrine islets of Langerhans produce hormones that
maintain glucose homeostasis. The pancreatic islets are comprised of a central core of
beta cells that produce insulin, surrounded by alpha, delta and epsilon cells that produce
the hormones glucagon, somatostatin and ghrelin respectively (Kinkel et al, 2009). The
hormones of the endocrine pancreas work together to maintain glucose homeostasis:
insulin inhibits the secretion of glucagon from alpha cells, while glucagon activates the
secretion of insulin and somatostatin from beta and delta cells, whereas somatostatin and
ghrelin inhibit insulin secretion (Figure 1) (Jiang et al, 2011).

Figure 1. The endocrine pancreatic hormones insulin, somatostatin, glucagon and
ghrelin are responsible for the regulation of glucose homeostasis. Insulin (mainly
responsible for glucose homeostasis) inhibits glucagon secretion from alpha cells.
Glucagon activates the secretion of insulin and somatostatin, whereas somatostatin and
ghrelin inhibit insulin secretion. (Jiang et al, 2011)
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The zebrafish pancreas is structurally similar to the mammalian pancreas, and
shares the same cellular makeup (Kinkel et al, 2009). During development, the pancreas
arises from the endoderm germ layer (from which the liver, gallbladder and intestine are
also derived) and differentiates into the exocrine and endocrine tissues (Warga et al,
1999). At the 24 somite stage of the developing zebrafish, the islet precursor cells of the
pancreas arise from endodermal progenitor cells and bud off dorsally from the gut, giving
rise to endocrine tissues that express insulin, along with other pancreatic hormones (Tiso
et al, 2009). Between 24 and 48 hours post fertilization (hpf), the rotating gut dislocates
this dorsal bud on the right side of the gut, forming an islet that is organized similarly to
the mammalian islet by 48 hpf (Tiso et al, 2009 and Biemar et al, 2001). The mature
zebrafish endocrine pancreas forms around 7 days post fertilization (dpf) and consists of
an organized mass of beta cells, surrounded mainly by alpha and delta cells that make up
the primary islet (Figure 2), and smaller secondary islets that are nested in the exocrine
tissues (Tiso et al, 2009).
Mammalian in utero systems do not allow for the direct observation of in vivo
organ, especially pancreatic, development. Organogenesis cannot be directly visualized
within the mammalian uterus, and tissue sampling is often invasive. In contrast, zebrafish
embryos are see-through, and do not develop in utero, allowing for the direct observation
of organ and whole-embryo development in vivo. As a result, the zebrafish model is
becoming increasingly used for developmental research, due to this species’ rapid
developmental growth, the numerous existing transgenic lines, and transparent embryos
that allow for real time imaging of morphologic development (Lieschke et al, 2007).
Because of these characteristics, the zebrafish has become a well-established model used
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to study human development and disease, including pancreatic development and
developmental glutathione redox dynamics (Tiso et al, 2009 and Timme-Laragy et al,
2013).
The Transgenic (ins-GFP) zebrafish line was created so that insulin expression is
represented by Green Fluorescent Protein (GFP) (diIorio et al, 2002). This line was first
generated by injecting approximately 5 nL containing 20 ng/L cesium-purified plasmid
DNA and 50 ng/mL Tc3A transposase mRNA into zebrafish embryos at the one to two
cell stage, creating single-copy insertions (diIorio et al, 2002). As a result, fluorescence
occurs whenever preproinsulin is transcribed, creating GFP as a marker in pancreatic beta
cells. Because beta cells produce insulin, during embryonic development, this is an ideal
strain that allows for the visualization and imaging of the endocrine pancreas in vivo in
real-time.

Figure
2. Location,
organization
and
pancreaticislet
islet.
Figure
2. Location,
organization
andcomposition
compositionofofthe
theadult
adult zebrafish
zebrafish pancreatic
(Kinkel et al, 2009)
(Kinkel et al, 2009).
1.3. Oxidative Stress
One factor implicated in T2D is oxidative stress. As defined by Jones et al, 2006,
oxidative stress is the “disruption of redox signaling and control.” Intrauterine oxidative
stress is known to be associated with an increased risk of developing T2D later in life
(Simmons et al, 2006). Due to their low expression of antioxidant enzymes, such as
4

superoxide dismutase, catalase, glutathione and glutathione peroxidase, pancreatic beta
cells are especially sensitive to oxidative stress (Lenzen et al, 1996). The most prevalent
endogenous antioxidant that defends against oxidative stress is glutathione (GSH), a
tripeptide of cysteine, glutamate and glycine. GSH is synthesized via two ATP-dependent
steps: 1) the enzyme glutamate-cysteine ligase (Gcl) combines glutamate and cysteine in
the rate-limiting step; 2) a glycine is added to the glutamate-cysteine molecule in a
reaction catalyzed by glutathione synthase (Gss) (Figure 3). GSH defends against
oxidative stress by scavenging reactive oxygen species (ROS) which oxidize the cysteine
moiety, and by acting as a co-factor for the antioxidant enzymes glutathione-S-transferase
(Gst) and glutathione peroxidase (Gpx) (Timme-Laragy et al, 2013). When GSH is
oxidized, it dimerizes and becomes glutathione disulfide (GSSG), which can be recycled
back into reduced glutathione (GSH) in a NADPH-dependent reaction, catalyzed by the
enzyme glutathione disulfide reductase (Gsr) (Figure 3) (Timme-Laragy et al, 2013).
Measured concentrations of GSH and GSSG can be applied to the Nernst equation
to calculate redox potentials (Eh) (Jones et al, 2006). Fluctuations in redox potentials play
an important role in normal embryonic development by guiding cell signaling, cell-fate
decisions and apoptosis (Hansen et al, 2013). More positive redox potentials indicate a
more oxidized redox state and are associated with cell differentiation and apoptosis,
whereas more negative redox potentials suggest a more reduced redox state and are
associated with cell proliferation (Schafer et al, 2001). Embryonic exposure to
environmental anthropogenic chemicals, such as parabens, may generate ROS that
disturb redox signaling and affect intracellular redox potentials, altering cell fate
decisions, and potentially leading to disrupted pancreatic islet structure and function.
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Figure 3. Glutathione synthesis and use. (Timme-Laragy et al, 2013)
1.4. Butylparaben
Parabens (para-hydroxybenzoic acids) are a family of alkyl esters that are
currently the most widely used preservatives in cosmetic and pharmaceutical products
due to their extensive range of antimicrobial activity. In fact, parabens are the most
common cosmetic ingredient after water (Cashman et al, 2005). Butylparaben is one of
the most commonly used parabens in commercial products after methyl- and
propylparaben. However, only a few studies have been conducted that investigate an
association between butylparaben and oxidative stress. Butylparaben has been found to
induce oxidative stress in the liver tissues of mice by significantly decreasing GSH
(43.87%) along with the enzymatic activities of GSH peroxidases and GSH-Stransferases (Shah et al, 2012). A study that measured GSH redox dynamics in the brain
tissues of developmentally exposed mouse offspring also found GSH and the GSH/GSSG
percent ratio to decrease and GSSG and percent GSSG to increase, suggesting the
occurrence of oxidative stress (Hegazy et al, 2015). Urinary butylparaben levels have
6

been shown to be associated with biomarkers of oxidative stress in humans (Kang et al,
2013). Watkins et al (2015) also found urinary butylparaben concentrations to be
significantly associated with 27 percent higher isoprostane (a urinary marker of oxidative
stress) and weakly associated with OHdG (a marker of oxidative stress to DNA).
Often combined to enhance antimicrobial effects, parabens differ due to the
specific R-group at the para position on the molecule’s benzene ring (Figure 4). The most
commonly used parabens are methyl-, ethyl, propyl-, benzyl-, and butyl-paraben. The
different alkyl groups give parabens a spectrum of antimicrobial effects with
antimicrobial activity and lipophilicity increasing with the length of the alkyl group
(Cashman et al, 2005). Parabens have been found to act as preservatives by increasing the
impermeability of bacterial cell membranes to proteins and other ions, and by penetrating
the phospholipid bilayer of bacterial cell membranes, displacing the phospholipid
molecules (Eklund et al, 1980). Parabens also obstruct amino acid uptake in bacterial
membrane vesicles, inhibiting bacterial growth, and have been found to interfere with
both RNA and DNA synthesis in bacteria (Eklund et al, 1980 and Nes et al, 1983).
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Figure 4. Chemical structures of seven different parabens. (Darbre et al, 2008)
Humans are most commonly exposed to parabens dermally. However, after all
routes of exposure, parabens are metabolized by carboxylesterases in the skin, liver,
linings of the intestine, and subcutaneous fat into metabolites: p-carboxyphenyl
glucuronide, p-hydroxybenzoyl glucuronide, and p-carboxyphenyl sulfate (Cashman et
al, 2005 and Soni et al, 2005). These carboxylesterase enzymes are both expressed and
active in zebrafish embryos as early as the 6 somite stage (Kuster et al, 2005).
Conventionally, it has been assumed that parabens are quickly absorbed and metabolized,
which originally contributed to the belief that parabens have low human toxicity.
However, parabens have been found to escape metabolism in the skin and intestine and
have been found in human urine, blood serum, and breast milk samples. Ye et al (2006)
discovered free, un-metabolized butylparaben in 69% of urine samples from subjects with
no known occupational exposures. Free butylparaben (an average of 135 µg/L) was also
found in the serum of young male volunteers who were exposed to cosmetics containing
8

butylparaben for one week (Janjua et al, 2007). Jimenez-Diaz et al (2011) also detected
an average of 0.4 ng/g-1 free butylparaben in human placental tissues.
A 1995 survey conducted on 215 cosmetic products found parabens in 99% of
leave-on cosmetics and 77% of rinse-off products (Rastogi et al, 1995). As of 2005, the
United States population is exposed to an average of 76 mg of parabens per day, with
butylparaben being the third most abundant exposure (Cashman et al, 2005). Early
estimates of human exposures to butylparaben in the United States due to long-term
cosmetic use range from 0.26 to 14.6 mg/day (Masten, et al 2005). In 2014, estimates of
the daily usage of cosmetic products that contain parabens were 17,760 mg for adults and
378 mg for infants (Anderson, 2008). According to the United States Food and Drug
Administration’s Center for Food Safety and Applied Nutrition, the United States
population consumes an average rate of 37 ng butylparaben per day. Parabens have also
been detected in adult urine samples as well as in the amniotic fluid of pregnant women
(0.3 µg/L) (Philippat et al, 2013), suggesting the potential for direct human fetal exposure
to parabens.
Parabens have also been shown to have endocrine disrupting effects.
Butylparaben has been found to interfere with the male and female reproductive system
by acting as a weak estrogenic chemical, and by hindering spermatogenesis.
Butylparaben was found to compete with [3H] estradiol for binding to estrogen receptors
in female rats, and revealed estrogenic responses in sexually mature rainbow trout
(Routledge et al, 1998, Pedersen et al, 2000). In both male rats and mice, butylparaben
exposure lowered serum testosterone in a dose-dependent manner, while decreasing
sperm count and daily sperm production (Oshi et al, 2001, and Oshi et al, 2002).
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Butylparaben has also been found to increase the release of the adipocyte
hormones leptin, resistin, and adiponectin through increased peroxisome proliferatoractivated receptor (PPARγ) activation (Taxvig et al, 2012). PPARγ is mainly expressed
in adipose tissues where it influences the storage of fatty acids and induces adipocyte
differentiation (Tontonoz et al, 1995). Because PPARγ plays a role in the regulation of
adipocyte differentiation, Taxvig et al show that, through PPARγ activation,
butylparaben stimulates lipid accumulation in differentiating adipocytes, which results in
an increase in the release of adipocyte related hormones. Hu et al (2013) also found
butylparaben to enhance adipocyte differentiation, increasing glucocorticoid activity in
addition to activating PPARγ. The potency of these effects was amplified with increasing
paraben alkyl chain length, with butylparaben displaying the largest magnitude of effect.
Obesity is known to be associated with an increased risk in developing T2D
(Kahn et al, 2006). The hormones leptin, adiponectin and resistin are all associated with
increased insulin resistance and increased risk for developing diabetes (Taxvig et al,
2012). Increased levels of circulating leptin has been associated with obesity, however
low fetal leptin levels may increase the risk of obesity and insulin resistance later in life
(Djiane et al, 2008). Adiponectin shows an inverse association with insulin resistance
(Taxvig et al, 2012). Resistin has been shown to regulate insulin sensitivity and
metabolism in different tissues (Steppan et al, 2001). Due to its interactions with
estrogen receptors, interfaces with hormones that are associated with insulin resistance,
and increased adipocyte differentiation, butylparaben may disrupt endocrine system
function.
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To date, no studies have been conducted that examine the effects of butylparaben
in the zebrafish model (Danio renio); however studies have been conducted using
propylparaben. Mikula et al, (2008) found that juvenile zebrafish exposed to 500 mg/kg⁻¹
propylparaben, administered in feed three times daily, influenced sex differentiation by
significantly skewing the sex ratio towards the female sex, suggesting propylparaben’s
ability to interfere with gonad development. Because sex differentiation in zebrafish is
influenced by hormones, this skewed sex ratio is most likely due to propylparaben’s
interference with the hypothalamo-pituitary-gonadal axis, suggesting endocrine
disrupting effects of parabens in vertebrates.
It is unknown whether butylparaben affects the developing pancreas. A
preliminary study in 1956 found butylparaben esters recovered in the pancreas of dogs
that were intra-venously administered 100 mg/kg butylparaben per day (Jones et al,
1956). However, no further studies have been conducted to investigate whether
butylparaben affects the developing pancreas. Because pancreatic beta cells have low
antioxidant levels and gene expression, they are more likely susceptible to oxidative
damage than the other cell types in the exocrine pancreas. This thesis tests the hypothesis
that daily butylparaben exposure will alter the development of the endocrine pancreas
with the possible involvement of oxidative stress.
1.5. Thesis Overview
This study aims to determine whether butylparaben may prompt structural and
functional changes in the beta cells of the endocrine pancreas, and to investigate whether
butylparaben induces oxidative stress in the developing zebrafish. Chapter 2 examines
how embryonic butylparaben exposure affects endocrine pancreatic development and
11

whole embryo morphological development in transgenic (ins-GFP) zebrafish. Embryos
were imaged at 3, 4, 5 and 7 days post fertilization; islet areas were measured and islet
deformities were quantified to determine whether butylparaben affects islet development
by altering islet area and morphology. Yolk sac area was also measured throughout
development to indicate metabolism and to determine the rate at which exposed embryos
utilize nutrients. Other morphological deformities were also quantified to determine
whether pancreatic islets are specifically sensitive to butylparaben. Gene expression of
the endocrine pancreatic hormone index was also quantified.
Chapter 3 identifies the impact of butylparaben on glutathione redox dynamics in
embryonic zebrafish. GSH and GSSG were quantified to determine redox potentials in
transgenic (ins-GFP) zebrafish embryos. Embryos endured exposures to 500 nM and
1,000 nM butylparaben and were collected for redox analysis at 24 and 28 hpf. Redox
potentials were determined using HPLC detection of soluble thiols. Expression of the
genes involved in glutathione synthesis, and utilization, including glutamate cystine
ligase subunits (gclc and gclm), glutathione synthetase (gss), glutathione disulfide
reductase (gsr) and glutathione S-transferase (gst) were measured at 3 days post
fertilization via qPCR, using β-actin as a housekeeping gene1. These studies aim to
determine: 1) whether embryonic exposure to butylparaben prompts structural and
functional changes in the developing endocrine pancreas and 2) determine whether
butylparaben induces oxidative stress that may contribute to islet morphology.
1

Regarding the gene and protein name formatting, the approved format for designing
genes and proteins (see the ZFIN Zebrafish Nomenclature Web site
https://wiki.zfin.org/display/general/ZFIN+Zebrafish+Nomenclature+Guidelines) was
used. Human genes and proteins are labeled using all capitals (INSA and INSA
respectively), and rodent genes and proteins are labeled Insa and INSA respectively.
Zebrafish genes and proteins are characterized as insa and Insa respectively.
12

CHAPTER 2
BURYLPARABEN ALTERS THE DEVELOPING PANCREAS
2.1. Introduction
Over the past few decades, the incidence of both Type 1 and Type 2 diabetes has
greatly increased in genetically stable populations, suggesting influential environmental
factors are contributing to this escalation. Early life exposures to environmental
chemicals may impact the development of the endocrine pancreas, and may contribute to
this escalated prevalence (Pitkaniemi et al, 2004). The pancreas is highly vascularized,
and is therefore likely exposed to environmental chemicals that are in the bloodstream.
Two main tissues make up the pancreas: the exocrine acinar tissues that produce
digestive enzymes, and endocrine islets of Langerhans that are composed of different
cells that produce hormones involved in the regulation of glucose homeostasis (Jiang et
al, 2011). The alpha cells of the endocrine islets produce glucagon that signals the
degradation of molecules such as glycogen for the production of free glucose. Epsilon
and delta cells produce ghrelin and somatostatin respectively, which negatively regulate
insulin and glucagon secretion. The beta cells of the endocrine pancreas are the only cells
that produce insulin, which promotes the absorption of glucose from the bloodstream
(Jiang et al, 2011). The transcription factor Pdx1 transcribes for both insulin and
glucagon.
The zebrafish pancreas is structurally similar to the mammalian pancreas and
shares this same cellular make-up (Kinkel et al, 2009). The zebrafish model is commonly
used in developmental toxicological research, especially due this model’s plethora of
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different transgenic lines. Here, using the transgenic ins-GFP line, the developing
pancreas can be observed in vivo in real time.
Butylparaben has been recovered in pancreatic tissues, and has been found in
human amniotic fluid, suggesting the possibility of direct human fetal and pancreas
exposure (Jones et al, 1956 and Philippat et al, 2013). To date, there are no studies that
observe whether butylparaben affects the developing pancreas. This study aims to
identify whether daily exposure to different environmentally relevant concentrations of
butylparaben affect the development of the endocrine pancreas in the zebrafish model.
Embryos were exposed daily to different environmentally relevant concentrations of
butylparaben and were imaged for pancreas and morphological deformities at time points
that are critical to pancreatic and embryonic development. Islet areas were also measured
and the incidences of islet deformities were calculated.
The developing islet is easily disrupted by any morphological deformities that
may be a consequence of butylparaben exposure. Therefore, embryonic gross
development was analyzed by measuring nose-to-tail embryonic length and yolk sac area
to indicate the embryos’ utilization of nutrients. The incidence and severity of
morphological deformities were also accounted for in a deformity index, and the
occurrence of morphological deformities were compared to the incidence of islet
deformities. Gene expression of the hormones involved in the regulation of insulin
homeostasis (glucagon, somatostatin, insulin and ghrelin) were measured along with the
transcription factor Pdx1. These experiments aim to determine whether butylparaben
prompts structural changes in the developing zebrafish pancreas.
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2.2 Materials and Methods
2.2.1 Chemicals
Butylparaben (Acros Organics, Thermo Fisher Scientific, Pittsburg, PA) was
acquired as a generous gift from Dr. Ling Zhao (Department of Nutrition, University of
Tennessee Knoxville, Knoxville, TN) dissolved in 0.01% v/v Dimethyl Sulfoxide
(DMSO) (Fischer Scientific, Pittsburg, PA). Solutions were stored at -20 ºC and vortexed
before each use.
2.2.2 Zebrafish Husbandry
Tg (ins-GFP) embryos were obtained from Dr. Phillip diIorio at the University of
Massachusetts Medical School Zebrafish Facility (Worchester, MA). This strain was
chosen due to its specific expression of green fluorescent protein in the beta cells of the
endocrine pancreas. Heterozygous nrf2afh318 embryos, that were crossed to obtain the
wildtype nrf2a+/+ embryos used in these experiments, were generated by the Tilling
Mutagenesis Project, obtained from the Moens Laboratory (Fred Hutchinson Cancer
Research Center, Seattle, WA) and acquired as a generous gift from Dr. Mark Hann of
the Woods Hole Oceanographic Institute (Woods Hole, MA).
All zebrafish used in these experiments were maintained under 14 hours of light
and 10 hours of darkness at 28.5̊C in an Aquaneering system, and adults were fed a diet
of Gemma Micro granule fish food (Skretting, Westbrook, ME) daily. Embryos were
collected from group matings of three 6 liter tanks of approximately 20 fish per tank with
a 1:2 male to female ratio. Embryos were maintained at low densities (approximately 30
embryos) in 10 mL 0.3x Danieau’s solution (17 mM NaCl, 2 mM KCl, 0.12 mM MgSO4,
1.8 mM Ca(NO3)2, 1.5 mM HEPES, pH 7.6) (Westfield et al, 2007). Embryo water was
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changed daily. All procedures are approved by the University of Massachusetts Amherst
IACUC committee (Animal Welfare Assurance Number A3551-01).
2.2.3. Survivorship
Wildtype zebrafish of the AB line, obtained from Boston Children’s Hospital
(Boston, MA), were used to observe survivorship. Embryos were exposed to
butylparaben concentrations of 1,000, 3,000 and 5,000 nM butylparaben, suspended in
0.01% (v/v) Dimethyl Sulfoxide (DMSO). This solvent was selected due to its lack of
toxicity in animal models. Butylparaben concentrations were chosen after a preliminary
dose range-finding experiment saw complete mortality following exposure to 10,000 nM
butylparaben.
Chemical exposures began at 3 hours post fertilization (hpf) and were replicated
daily until 72 hpf. This exposure regime was used for two key reasons: 1) the literature
suggests that parabens are rapidly metabolized, within 24 hours of exposure in rabbit
models (Soni et al, 2005), and 2) it is assumed that the majority of human paraben
exposure is due to cosmetic applications, so re-dosing daily will most accurately mimic
human exposure patterns.
Embryos were collected and screened approximately one hour after fertilization
and were divided into four groups, each group containing 30 embryos. Each group of 30
embryos was placed in a glass Petri dish containing 20 mL of 0.3x Danieau’s solution
and 0.01% (v/v) DMSO, 1,000, 3,000 or 5,000 nM butylparaben. Embryos were then
individually placed into 96-well plates, with 200 µL of their respective dosed water, and
imaged using Evos FL auto inverted fluorescent microscope (Life Technologies,
Pittsburgh, PA) to check for fertilization. Exposures and whole-embryo imaging was
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repeated at 24, 48 and 72 hpf with one trial of approximately 27-30 embryos per
treatment. Embryos were maintained in 96-well plates throughout the experiment.
Observations of mortality, heartbeat, yolk sac coagulation, hatching status, and
pericardial and yolk sac edema were recorded at each time point.
2.2.4. No Observed Effect Concentration (NOEC)
In order to determine the no observed effect concentration (NOEC) of
butylparaben exposure to the pancreatic islet, Tg (ins-GFP) embryos were exposed daily
to concentrations of 62.5, 125 and 250 nM butylparaben. Embryos were imaged and
analyzed at 4 days post fertilization. Exposures and imaging were carried out as described
above. Images were taken at 40x magnification to screen embryos for developmental
malformations, and at 100x and 200x magnification under trans and GFP overlaid filters
to image pancreatic islets. Islet areas were measured blindly using EVOS software and
islet deformities were quantified. This procedure was repeated twice with 10 embryos per
treatment.
2.2.5. Chemical Exposures
In order to expose embryos to a wide range of butylparaben concentrations in
both imaging and gene expression experiments, embryos were exposed to 0.01% (v/v)
DMSO or 250, 500, 1,000, or 3,000 nM butylparaben in 20 µL of 0.3x Danieau’s. These
concentrations were chosen after preliminary data from the survivorship study were
analyzed due to their low production of morphological abnormalities and low mortality
rates. Exposures began at 3 hpf and were renewed daily with water changes (0.3x
Danieau’s solution) until 7 days post fertilization (dpf). Embryos in all experiments were
manually dechorionated at 1 dpf using watchmaker’s forceps.
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2.2.6. Microscopy
Islets, islet morphology and embryonic developmental morphology were imaged
in Tg (ins-GFP) embryos at 3, 4, 5 and 7 dpf. Images were obtained with an EVOS AutoFL Inverted microscope (Life Technologies, Pittsburgh, PA). At each imaging time point,
embryos were anesthetized with MS222 (tricaine) in 0.3x Danieau’s solution and then
placed into individual drops of 3% methylcellulose in a right lateral orientation. Images
were taken at 20x and 40x magnification under a trans filter, and at 100x and 200x
magnification under trans and GFP filters using Evos FL auto inverted fluorescent
microscope (Life Technologies, Pittsburgh, PA). After imaging, all embryos were washed
in 20 mL of 0.3x Danieau’s, re-dosed with their respective treatment and stored at
28.5oC.
2.2.7. Imaging Analysis
All islet images used in islet area analysis were taken at 200x magnification, and
islet area was measured blindly using EVOS software. Islets that were not in focus or that
were occluded by pigmentation were excluded (approximately 1-4 embryos per
concentration per trial). Three categories of islet deformities were observed: islet
fragmentation (where the beta cells of the islet are more dispersed), ectopic beta cells
(where a beta cell emerges away from the primary islet), and “fuzzy” islets (whose fuzzy
appearance is not an artifact of the imaging process). To quantify whether butylparaben
affected embryonic gross development, yolk sac area (a surrogate measure of the
embryo’s ability to uptake nutrients) and whole embryo nose-to-tail lengths (to measure
embryo growth) were measured using EVOS software. Because the swim bladder is
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derived from the same progenitor endoderm cells as pancreatic beta cells, delayed swim
bladder inflation was also evaluated (Kimmel and Meyer, 2010).
A total deformity index was created to quantify the five developmental
deformities observed with butylparaben exposure. These deformities include: pericardial
edema (fluid retention in the membrane surrounding the heart), decreased yolk sac
utilization (increased yolk sac contents), intestinal effusion (fluid retention in the
intestinal lumen), craniofacial malformations and spinal malformations. Each deformity
was scored on a scale from 0-3, with 0 as normal, 1 for a mild deformity, 2 for a
moderate deformity and 3 for a severe deformity. A deformity index was then calculated
as the sum of scores for each individual embryo in each dose group at each time point
divided by the maximum score possible, and multiplied by 100. This approach is in
agreement with other deformity assessments in fish embryo models (Harbeitner et al,
2013, Wassenberg et al, 2004, and Whitehead et al, 2010).
2.2.8. RNA Extraction and Reverse Transcription
Wildtype nrf2a+/+embryos (5 biological replicates of approximately 10-12
embryos per treatment) were exposed daily to DMSO, 250, 500, 1,000 or 3,000 nM
butylparaben and collected for RNA isolation at 3 days post fertilization. Samples were
stored at -80ºC in 100 µL RNA Later. Prior to RNA extraction, all materials and surfaces
were sprayed with RNase Away® (Molecular Bio Products). RNA extractions were
carried out according to the GeneJET RNA Purification Kit Total RNA Purification
Protocol (Thermo Fisher Scientific Inc., Waltham, MA). Samples were sonicated for
approximately one second at 15 % amplification with a Branson Digital Sonifier®
(Danbury, CT) that was sterilized with 75% ethanol between each sonication. RNA
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concentration and quality was analyzed using a BioDrop µLITE (BioDrop, Cambridge,
UK). Reverse transcription to cDNA was carried out according to the manufacturer’s
protocol using an iScript cDNA synthesis kit for reverse transcription PCR (Bio-Rad
Laboratories, Hercules, CA) with a final concentration of RNA of 500 ng/ 15 µL RNA.
Synthesis was then carried out in an Eppendorf Mastercycler® nexus gradient thermal
cycler (Eppendorf, Hauppague, NY) according to the reaction protocol provided by
iScript.
2.2.9. Quantitative real-time PCR
To gain insight about the function of beta cells, the transcription of genes in the
pancreatic endocrine hormone axis was measured. Gene expression of the pancreatic
hormones preproinsulin a (insa), glucagon a (gcga), ghrelin (ghrl), and somatostatin 2
(sst2) and the transcription factor pancreatic duodenal homeobox 1 (pdx1) were
quantified with β-actin utilized as a housekeeping gene. β-actin is a known housekeeping
gene used with the zebrafish model, and its expression has not been shown to change due
to chemical exposures (McCurley and Callard, 2008).
All primers were first tested for specificity and efficiency. Primers were designed
using Primer-BLAST (NCBI) and were optimized for melting temperature and for
dimerization, to avoid both homodimer and heterodimer dimerization. cDNA was diluted
to a working concentration of 0.125 ng/µL, as previously performed by Rousseau et al
(2015). A 20 µL PCR reaction was carried out that contained 0.5 µL of each foreword
and reverse primer, 10 µL of 2x iQ™ SYBR® Green Supermix (Bio-Rad), 5 µL of
nuclease-free water, and 4 µL of diluted cDNA. Quantitative real-time PCR (qPCR) was
performed in a Bio-Rad CFX Connect™ real-time system under the conditions of 2
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minutes at 95ºC followed by 10 seconds at 95ºC, and then 25 seconds at 60-68ºC
depending on the melting temperature of each primer. A dissociative curve was created
for each primer run. The primer sequences (5’-3’ orientation) used for the pancreasrelated genes gcga, insa, pdx1 and housekeeping gene β-actin are listed in Table 1. The
primers for sst2, and ghrl were purchased from Bio-Rad (PrimePCR™). Data obtained
from qPCR were analyzed using the Bio-Rad CFX Connect Manager™ software, version
3.0 (Bio-Rad). The ddCT method was used to calculate fold change.

Table 1. Primer sequences of pancreas-related genes gcga, insa, pdx1 and housekeeping
gene β-actin.
Gene
gcga
insa
pdx1
β-actin

Primer Sequence 5'-3'
Foreword
Reverse
Foreword
Reverse
Foreword
Reverse
Foreword
Reverse

GGACAACCCAAACCAGATGTT
CCTGACGCCTTCGAGTTCAT
GCCCAACAGGCTTCTTCTACAAC
GCAGATTTAGGAGGAAGGAAACCC
CATCTCTACAGTCGCTCGGG
ACCATATAAGGGCCTGTCCAC
CAACAGAGAGAAGATGACACAGATCA
GTCACACCATCACCAGAGTCCATCAC

2.2.10. Statistical Analysis
Data was analyzed using Microsoft Excel and Stata statistical software, version
14.1. All statistical tests were performed by Stata. Two-factorial ANOVAS followed by a
Tukey’s post hoc test or a Wald’s post hoc test were used to test for effects among
exposed groups and controls. Logistic regression analysis was performed to determine
significance for swim bladder data and a Mann-Whitney U test was used to analyze the
deformity index. Probit analysis was performed to analyze survivorship. A McNemar’s
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test for significance was used to determine independence between islet deformities and
morphological deformities. Data are presented as the mean and the standard error of the
mean (SEM).
2.3. Results
2.3.1. Survivorship
In order to assess embryonic survivorship in response to daily butylparaben
exposure, survivorship analysis was performed daily until 3 days post fertilization. The
control (DMSO) and 1,000 nM groups retained 96% and 92% survivorship throughout all
time points respectively. Survivorship in the 3,000 nM group decreased from 88% to
85% survivorship at 3 dpf. Survivorship in the 5,000 nM group decreased from 89% to
85% over the three day exposure (Figure 5).
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Figure 5. Survivorship of wildtype embryos after exposure to 3 different
concentrations of butylparaben. Thirty embryos per treatment were exposed to 0.01%
(v/v) DMSO, 1,000, 3,000 or 5,000 nM butylparaben. Survivorship was observed daily
until 3 days post fertilization.
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2.3.2. Butylparaben Disturbs Pancreatic Islet Development
To determine the low-dose toxicity of butylparaben on islet development, the
NOEC was calculated for islet area and defects. Islet area increased in a dose-dependent
manner (Figure 6). However, this trend was only significant at the highest concentration
(250 nM) (p< 0.05). Here, the lowest observed effect level concerning islet area was 250
nM, and the no observed effect level was 125 nM. Butylparaben also induced islet
deformities at 250 nM, with 70% of islets displaying a malformation compared to 20% of
embryos exposed to 125 nM, and 0% of embryos exposed to 62.5 nM and 22 % of the
controls (Table 2).
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Figure 6. Islet areas are sensitive to butylparaben down to concentrations of 250 nM
at 4 dpf. Transgenic (ins-GFP) embryos were exposed daily to 62.5, 125 and 250 nM
butylparaben (n= 15-20 embryos per treatment). Imaging was performed at 4 dpf under a
trans and GFP filter using EVOS imaging software. Islet areas were measured using
EVOS software editing tools. p<0.05.
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Table 2. Incidences of total and specific islet deformities in embryos exposed daily to
DMSO, 62.5, 125, or 250 nM butylparaben at 4 dpf.

Total Defects
Fragmented
Ectopic
Fuzzy

Control

62.5 nM

125 nM

250 nM

3/14 (21%)
2/14
1/14
0/14

1/19 (5%)
1/19
0/19
0/19

4/16 (25%)
1/16
3/16
0/16

9/17 (53%)
1/17
5/17
3/17

In order to quantify beta cell development, the area of islet fluorescence was
measured at the time points of 3, 4, 5 and 7 days post fertilization. Butylparaben exposure
was found to significantly increase islet area by as much as 55%. Islet area increased
significantly for all concentrations of butylparaben when compared to controls at 3 dpf
(p< 0.05) (Figure 7). Embryos exposed to 250 nM butylparaben had islet areas that were
significantly larger than controls at all time points (3, 4, 5 and 7 dpf). At 4 dpf, islet area
was significantly greater in embryos exposed to 250 and 500 nM butylparaben, and at 5
dpf only embryos exposed to the lowest concentration of 250 nM saw a significant
increase in islet area. At 7 dpf, islet area was significantly greater in embryos exposed to
the lowest (250 nM) and highest (3,000 nM) concentrations of butylparaben (p<0.05)
(Figure 7).
Islet area was also seen to increase over time until 5 dpf and then decrease at 7
dpf. However, exposure to 3,000 nM butylparaben decreased islet area at all time points
when compared to areas at 3 dpf (Figure 8).
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Figure 7. Daily exposure to butylparaben increases islet area over 7 days. Transgenic
ins-GFP zebrafish were exposed daily to 250, 500, 1,000, and 3,000 nM butylparaben
and imaged under a GFP filter using EVOS Auto-FL Inverted microscope software at 3,
4, 5 and 7 days post fertilization. Islet areas were measured using the EVOS software
editing tools (n= 15-25 embryos). A one-factor ANOVA followed by a Tukey’s post hoc
test was utilized to test for effects among exposed groups and controls. Means sharing a
letter in the group label are not significantly different at the 5% level.
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Figure 8. Islet area decreases over time with butylparaben treatment. Transgenic insGFP zebrafish were exposed daily to 250 nM, 500 nM, 1,000, and 3,000 nM
butylparaben and imaged under a GFP filter using EVOS Auto-FL Inverted microscope
software at 3, 4, 5 and 7 days post fertilization. Islet areas were measured using the
EVOS software editing tools (n= 15-25 embryos). A two-factorial ANOVA followed by
a Wald post hoc test was used to test for effects among exposed groups and controls (p<
0.05).

Exposure to butylparaben also resulted in irregular development of the pancreatic
islet that was observed at 3-7 dpf. The three most prevalent deformities observed were
fragmentation of the beta cells, where the beta cells of the islet appear more dispersed
(Figure 9.B.), ectopic beta cells, in which a beta cell emerges away from the primary islet
(Figure 9.C.) and “fuzzy” islets, where the fuzzy appearance is not an artifact of the
imaging process (Figure 9.D.). The incidence of these deformities changed with
butylparaben exposure. Fragmented islets were most prevalent at the 250 nM
concentration (44%), whereas ectopic beta cells were most prevalent at 500 nM (16%),
and “Fuzzy Islets” were predominant at 3,000 nM (54%) (Table 3). Between 3 and 7 dpf,
90% of control embryos displayed normally developed islets compared to 53% of the 250
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nM group, 75% of the 500 nM group, 71% of the 1,000 nM group, and 67% of embryos
exposed to 3,000 nM groups. Three day post fertilization embryos that were exposed to
250 nM and 3,000 nM butylparaben had the greatest incidence of total islet defects (56%
and 58% respectively) (Table 3). Islet fragmentation decreased over time, whereas the
prevalence of “Fuzzy Islets” appeared to decrease over time at the higher concentrations
of 1,000 nM and 3,000 nM, but increased at the lower concentrations of 500 nM and 250
nM butylparaben (Table 3). There are no obvious trends relating to the incidence of
ectopic beta cells. It is important to note that these malformations may contribute to
increased islet size.

27

Table 3. Incidences of specific and total islet deformities: Fragmented, Ectopic and Fuzzy.

Total
Defects

Total
Defects

Total
Defects

Total
Defects

Total
Defects

3 dpf

4 dpf

5 dpf

7 dpf

Control
Fragmented
Ectopic
Fuzzy

2/23 (9%)
1/23
0/23
1/23

3/23 (13%)
2/23
1/23
0/23

3/23 (13%)
1/23
2/23
0/23

1/21 (4%)
0/23
0/21
1/23

250 nM
Fragmented
Ectopic
Fuzzy

9/16 (56%)
7/16
1/16
1/16

8/16 (50%)
7/16
1/16
0/16

7/16 (44%)
5/16
2/16
0/16

6/16 (38%)
4/16
0/16
2/16

500 nM
Fragmented
Ectopic
Fuzzy

8/25 (32%)
3/25
4/25
1/25

4/24 (16%)
2/24
2/24
0/24

5/24 (21%)
0/24
2/24
3/24

7/24 (29%)
2/24
1/24
4/24

10/25(40%)
1,000 nM
Fragmented
4/25
Ectopic
1/25
Fuzzy
5/25

9/25 (36%)
5/25
3/25
1/25

4/25 (16%)
0/25
2/25
2/25

6/25 (24%)
2/25
2/25
2/25

15/26(58%)
3,000 nM
Fragmented
1/26
Ectopic
0/26
Fuzzy
14/26

11/26 (42%)
0/25
1/25
10/25

6/26 (23%)
1/25
2/25
2/25

2/26 (8%)
1/26
0/26
1/26
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Figure 9. Examples of islet deformities at 4 dpf. Images were taken at 200x
magnification after daily exposure to butylparaben in Tg(ins-GFP) embryos. A) Control
(DMSO) embryos have characteristically spherical islets. B) Fragmentation of the islet.
C) An ectopic beta cell. D) Islet is fuzzy, focus was not obtainable through the imaging
process. Images are overlaid Trans and fluorescent GFP images taken at 200x
magnification. These deformities are observed at 3, 4, 5 and 7 dpf

2.3.3. Developmental Toxicity of Butylparaben
To determine the effects of butylparaben on embryonic development, embryos
were analyzed for developmental deformities. Tg (ins-GFP) embryos were exposed daily
to concentrations of 250, 500, 1,000 and 3,000 nM butylparaben, and were imaged at 3,
4, 5 and 7 dpf. Five developmental deformities were used in a deformity index:
pericardial edema, underutilized yolk sac, intestinal effusion, craniofacial malformations
and spinal malformations (Figure 10.B). Butylparaben increased total deformities in a
dose-dependent manner. Embryos exposed to the lowest concentration, 250 nM, did not
show more deformities when compared to the controls at any time point. The highest
concentration, 3,000 nM, significantly increased total deformities at all time points
(p<0.0001). Embryos exposed to 500 nM butylparaben only showed more deformities at
3 and 7 days post fertilization, and those exposed to 1,000 nM saw significantly more
deformities at 3, 4, and 7 dpf (Figure 10.A). At 3 dpf, butylparaben exposures greater
than 250 nM significantly increased total deformities when compared to the controls
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(Figure 10.A.). It is important to note that some embryos displayed multiple deformities.
However most embryos were not deformed at all, and the majority of embryos that were
deformed did not have any islet defects.
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Figure 10. Deformity index for total morphological deformities and examples of
morphologic deformities. A. Deformity index for total morphologic deformities.
(Max Deformity Score = 100) Total developmental deformities including pericardial
edema, underutilized yolk sac, intestinal effusion, craniofacial malformations and spinal
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malformations. Tg(ins-GFP) embryos were exposed to 250, 500, 1,000 and 3,000 nM
butylparaben daily (5-10 embryos per treatment for 4 trials) and imaged using EVOS
Imaging software at 40x magnification. *=p<0.05, **=p<0.0001. B. Examples of
morphologic deformities. Specific developmental deformities including pericardial
edema, underutilized yolk sac, intestinal effusion, craniofacial malformations, and spinal
malformations increase in severity from 1-3 at 3-7 dpf. Images were taken at 40x
magnification in Tg(ins-GFP) embryos exposed daily to DMSO, 250, 500, 1,000, and
3,000 nM butylparaben.
To observe the effects of butylparaben on gross embryonic development, yolk sac
utilization and embryonic growth were quantified. Embryonic yolk sac areas were
measured at 3, 4 and 5 dpf to measure nutrient uptake. We found no significant
relationship between butylparaben concentration and yolk sac area. Although a trend in
smaller yolk sac area was seen throughout all time points at the 250 nM exposure, this
trend was not significant (Figure 11.A.). Embryonic growth was quantified by measuring
nose-to-tail linear length. Similarly to yolk sac area, embryonic body length was not
significantly affected by butylparaben at any concentration from 3-7 dpf (Figure 11. B.).
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Days Post Fertilization

Days Post Fertilization

Figure 11. Gross development is not significantly affected by daily butylparaben
exposure. Tg(ins-GFP) embryos were treated daily with 250, 500, 1,000 and 3,000 nM
butylparaben (n=30 embryos per treatment for 4 trials). Yolk sac areas and embryonic
nose-to-tail lengths were measured to determine embryonic yolk sac utilization and
embryonic growth at 3, 4, and 5 dpf using EVOS software editing tools. A two factor
ANOVA was utilized to test for affects among exposed and control groups.
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In addition to embryonic growth, swimbladder inflation in response to chemical
exposures is an endpoint that is often observed in the zebrafish model. Because the
teleost swim bladder is derived from the same progenitor endoderm layer as the pancreas,
we examined the effect of butylparaben on swim bladder inflation at 4, 5, and 7 days post
fertilization. Throughout all time points, there was a trend in increased swim bladder
inflation at 250 nM when compared to controls, though this trend was only significant at
4 dpf. Swim bladder inflation significantly decreased at the highest concentration (3,000
nM) by 40%, 62 %, 50% when compared to the controls at 4, 5 and 7 dpf respectively (p
< 0.05) (Figure 12). The concentrations of 500 and 1,000 nM butylparaben did not affect
swim bladder inflation when compared to the controls.
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Figure 12. Percent swimbladder inflation at 4, 5 and 7 dpf. Tg (ins-GFP) embryos
were treated daily with 250, 500, 1,000 and 3,000 nM butylparaben (n=30 embryos per
treatment). Inflated swimbladders were quantified for each treatment. Logistic regression
was used to determine differences among control and exposed groups (p<0.05).
To further investigate whether these developmental morphologies may be
contributing to the occurrence of islet deformities, the relationship between the specific
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morphologic deformities (swimbladder inflation, intestinal effusion, spinal
malformations, decreased yolk sac utilization, pericardial edema, and craniofacial
malformations) and islet architecture was observed using a McNemar’s test for
independence. P-values produced by this test that are greater than 0.05 indicate the
relationship between the specific morphologic deformity and the occurrence of islet
deformities occur independently. P-values that are less than 0.05 indicate a lack of
independence. Here, the relationship between specific morphologic deformities and the
occurrence of pancreas deformities was measured in control groups and embryos that
were exposed to 250 and 3,000 nM butylparaben at 4 dpf. No clear relationship was
observed between the occurrence of developmental deformities and islet architecture
(Figure 13). However, it is interesting to note that these relationships change based on
exposure (Figure 13).
Deformity
Swimbladder Inflation
Intestinal Effusion
Spinal Malformations
Decreased Yolk Utilization
Pericardial Edema
Craniofacialmalformations

Controls
0.005
0.083
0.157
0.561
0.650

250 nM
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0.256
0.005
0.008
0.005

3,000 nM
0.001
0.124
0.003
0.739
0.739

1.000

0.004
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Figure 13. The relationship between morphologic deformities and islet architecture.
The relationship between specific morphologic deformities and the occurrence of islet
deformities in control groups and embryos that were exposed to 250 and 3,000 nM
butylparaben at 4 dpf (n= 30 embryos per treatment). A McNemar’s test for
independence was performed to investigate whether these relationships are independent.
2.3.4. Expression of Pancreas-related Genes
To assess the effects of butylparaben on beta cell function, the gene expression of
the pancreatic endocrine hormone axis was measured. Gene expression of the pancreatic
hormone index: preproinsulin a (insa), glucagon a (gcga), ghrelin (ghrl), and
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somatostatin 2 (sst2) was measured using a real-time quantitative polymerase chain
reaction (qPCR). The transcription factor pancreatic duodenal homeobox 1 (pdx1) was
also measured, and β-actin was utilized as a housekeeping gene. There was no significant
relationship between butylparaben exposure and the gene expression of the pancreatic
hormone index. However, the expression of pdx1 was significantly downregulated at the

Gene Expression (Fold Change)

highest concentration (3,000 nM) (Figure 14).
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Figure 14. Pdx1 is downregulated at the 3,000 nM butylparaben exposure. Wildtype
embryos were exposed daily to DMSO, 250, 500 or 3,000 nM butylparaben, and were
collected at 78 hpf. Expression of pdx1 was measured and the ddCt method was used to
calculate fold change, followed by pairwise T-tests to calculate significance (p< 0.05).
N= 5 biological replicates per group with each replicate containing pools of 10-13
embryos.
2.4. Discussion
The endocrine pancreas is highly vascularized and is therefore likely exposed to
chemicals, such as parabens, that may be in the blood stream. There is great potential for
human exposure to butylparaben, and it has been recovered in pancreatic tissues and in
human amniotic fluid at concentrations of 0.3 µg/L. In this study, I hypothesized that
butylparaben would affect the development of the pancreatic islet. To test this hypothesis,
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I analyzed whether butylparaben alters the development of the endocrine pancreas while
observing butylparaben’s effects on gross development in zebrafish embryos.
The data from this study indicate butylparaben affects islet development by
increasing islet area and increasing the incidence of islet deformities. The cause of this
increasing islet area with butylparaben exposure is unclear, however some potential
explanations include increased islet area due to fragmentation of the islet cluster,
augmented beta cell proliferation, larger beta cell size due to greater numbers of cell
vacuoles, amplified beta cell differentiation, and increased islet area due to the increased
presence of “fuzzy” islets.
Embryos that were exposed to the lowest concentration (250 nM butylparaben)
had islet areas that were significantly larger than controls at all time points analyzed (3, 4,
5 and 7 dpf). This could be due to the dispersion of the islet cluster into fragmented cells,
where an average of 36% embryos exposed to the 250 nM concentration had fragmented
islets over all time points compared to 4% of controls, 7% of embryos exposed to 500
nM, 11% of embryos exposed to 1,000 nM and 3% of embryos exposed to 3,000 nM
(Table 3). Another zebrafish study has also found islet dispersion or fragmentation to
increase islet area, as seen in embryos that were exposed to 5 nM PCB-126 (TimmeLaragy et al, 2015). Butylparaben-induced cell dispersion has also been shown in rodent
models. Alam et al (2013) found butylparaben to cause the collapse of rat Sertoli cell
vimentin filaments, allowing spermatogenic cells to become separated from the Sertoli
cells and become more dispersed. Butylparaben treatment also increased the size and
number of Sertoli cell vacuoles in a time and dose-dependent manner (Alam et al, 2013).
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Here, an increased number of vacuoles in beta cells could increase beta cell size and
potentially increase islet area.
Greater islet area could also be caused by augmented cell differentiation of beta
cell progenitors. Butylparaben has been found to increase cell differentiation, however
only in adipocyte cells, demonstrating a limitation of the existing literature. Hu et al
(2013) found butylparaben, in the presence of a differentiation cocktail, to increase
adipocyte differentiation when compared to cells exposed to DMSO. Parabens have also
been found to enhance adipocyte differentiation with increasing alkyl chain length, with
butylparaben promoting the most adipocyte differentiation. Taxvig et al (2012) also
found butylparaben to promote the differentiation of pre-adipocyte fibroblasts into
adipocytes.
The increased incidence of “fuzzy” islets could also be contributing to the larger
islet areas observed at the highest concentration (3,000 nM). The cause of this “fuzzy”
deformity is still unclear. Butylparaben acts through altering cell membrane properties,
and has been shown to allow intercellular solutes to leak from cells by changing cell
membrane integrity (Doron et al, 2001 and Furr et al, 1972). It is possible that
butylparaben may affect the cell membrane integrity of beta cells in a similar way,
causing them to become “leaky” and to appear fuzzy under the microscope. However, if
butylparaben were causing the membranes of beta cells to become leaky, it is likely that
the membranes of other cells may become leaky as well and appear “fuzzy” under a trans
filter. Therefore, further analysis is needed to determine whether the beta cell membranes
in these “fuzzy” islets are leaking. Future studies will utilize confocal and histological
analysis of these fuzzy islets to examine islet architecture.
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It is also possible that the “fuzzy” islets have not aligned properly during
development, and have not fully migrated to the right side of the embryo, causing the
islets to be visually distorted by the yolk sac. Other environmental chemicals such as
PCB’s have been found to interfere with zebrafish islet migration during development.
Zebrafish embryos treated with PCB-126 revealed islets that aligned with the third somite
rather than the fourth somite between 24 and 48 hpf (Timme-Laragy et al, 2015). Future
studies will image embryos that display fuzzy islets ventrally to view islet position and to
discover whether butylparaben disrupts islet alignment.
Data from this study also indicate that 250 nM is the lowest concentration in
which butylparaben impacts islet development. In this study, the lower concentrations of
62.5 nM and 125 nM appeared to increase islet area in a dose-dependent manner
however, this trend was not significant. As a result, because the lowest concentration in
which significant pancreatic effects were observed was 250 nM, it is possible that 250
nM (0.0485 mg/L) butylparaben is the LOEC for islet deformities in zebrafish. The
lowest concentration in which no significant islet defects occurred was 125 nM,
suggesting 125 nM may be the concentration in which no effects are observed, or the
NOEC. When exposed to butylparaben daily for 7 days, fatheaded minnows were found
to experience a NOEC of 1.0 mg/L butylparaben (Dobbins et al, 2009) and a LOEC of
2.0 mg/L, or 10,297 nM when looking at embryonic growth as an outcome. This is
evidence that the pancreas is a more sensitive endpoint in terms of butylparaben
exposure.
To further investigate the disrupted islet development, I measured the gene
expression of the pancreatic hormone index (insa, gcga, sst2 and ghrl) and the
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transcription factor pdx1. Exposure to butylparaben only significantly decreased the
expression of pdx1 at the highest concentration (3,000 nM), however exposure did not
significantly affect the expression of the pancreatic hormone index. Pdx1 plays a role in
regulating beta cell function by regulating the expression of insulin. Unlike the hormones
of the pancreatic hormone index, Pdx1 is redox sensitive, and can be regulated by the
redox state in cells (Rozenfeld et al, 2012). In vitro, Pdx1 activity has been found to
decrease with the induction of oxidative stress (Matsuoka et al, 2007). Additionally, Pdx1
has been found to increase in islets of mice treated with antioxidants N-acetyl cysteine
(NAC) and Vitamin C (Kaneto et al, 1999). If only oxidative stress were occurring here,
it would be expected that pdx1 gene expression may be affected. However, if Pdx1
activity were to be affected as well, it would likely be reflected in the transcriptional
activity of Pdx1, for example, in the transcription of insulin. Because the expression of
the pancreatic hormone index does not appear to change in response to the changes pdx1
expression, it is unclear whether the activity of Pdx1 is affected. Here, the decrease in
pdx1 expression could be a product of oxidative stress, however it is still unclear whether
this reduction in pdx1 expression is contributing to the disrupted islet development that
we are seeing at this concentration. Since Pdx1 transcribes for insulin, it would be
expected that insulin expression would be downregulated along with pdx1. However,
here we are seeing no effects on insulin gene expression. It is possible that transcription
factors upstream of Pdx1 are being affected. The forkhead/winged helix transcription
factor (Foxa2) (formerly HNF-3β) is an essential regulator in the development of the
foregut, that also plays a role in the beta cell-specific transcription of Pdx1 (Wu et al,
1997). It is possible that butylparaben decreases the activity of Foxa2, which would result
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in the decreased expression of pdx1. Future studies are needed to observe whether
butylparaben exposure changes the gene expression of foxa2.
The endocrine pancreas can be easily altered by other morphological deformities
that occur. In this study, embryonic gross development and the incidence of
morphological deformities were accounted for to determine whether butylparaben affects
morphological development, and whether these developmental deformities may be
causing the altered islet development that we are seeing. Yolk sac utilization and
embryonic growth were measured to determine whether butylparaben affects embryonic
gross development. In zebrafish embryos, yolk sac area often increases due to an
accumulation of edema fluid in the yolk sac, and due to a decrease in absorption of yolk
sac nutrients. The yolk sac is mainly comprised of fatty acids, and free fatty acids have
been found to regulate the secretion of insulin from beta cells, and have also been found
to cause beta cell apoptosis in rat islets, providing a mechanism by which obesity can
lead to the development of type 2 diabetes (Itoh et al, 2003 and Cnop et al, 2001). To
measure the utilization of nutrients through the yolk sac, embryonic yolk sac areas were
measured at 3, 4 and 5 dpf. Due to previous studies that suggest exposure to
environmental chemicals inhibit yolk sac utilization in both mouse and zebrafish embryo
models, it was originally believed that butylparaben exposure would cause yolk sac areas
to increase. DEHP, which is similar to butylparaben because it also activates PPARγ, was
seen to significantly inhibit yolk sac utilization in mice in a dose-dependent manner (Sant
et al, 2016). Exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) significantly
increased yolk sac area in exposed zebrafish embryos at 120 hpf (Prasch et al, 2003).
Similarly, increasing copper concentrations resulted in significantly larger yolk sacs in
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zebrafish embryos at 72 hpf (Johnson et al, 2007). Because no significant trend
concerning the effects of butylparaben on yolk sac area was observed, it appears that
butylparaben does not significantly affect the utilization of nutrients at the concentrations
tested.
Embryo nose-to-tail length was also used as a measurement of gross development.
In this study, body length was not significantly affected by butylparaben at any
concentration at any time point measured. This may be because the concentrations tested
are too low to affect embryo length. When observing the effects of PFOS on zebrafish
body length, Shi et al (2008) found that the lower concentrations of 0.1, 0.5 and 1 mg/L
PFOS did not significantly affect embryo length at 84 and 96 hpf, however, PFOS
significantly inhibited larval growth when exposed to 3 and 5 mg/mL PFOS. As stated
above, Dobbins et al (2009), found the LOEC for butylparaben on fat headed minnow
growth to be much greater than the concentrations that are tested here (10,297 nM vs.
3,000 nM), suggesting embryonic growth is less sensitive to butylparaben exposure, and
the concentrations used in the current experiment are too low to see a significant effect.
The incidence and severity of all deformities were also accounted for in a
deformity index. Some morphologic deformities occurred with butylparaben exposure,
however most embryos did not have any deformities, and no relationship was observed
between developmental deformities and islet architecture, suggesting the pancreas might
be a sensitive target tissue of butylparaben. The first exposure assessment of the
developmental toxicity of butylparaben in rats found no significant effects on fetal gross
development, soft tissue alterations or skeletal alterations at all oral doses tested, with a
maximum concentration of 1,000 mg/kg/day (Daston et al, 2004). However, to date, no
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studies have been found to exist that account for or quantify the incidence of
morphological deformities in response to butylparaben exposure in a fish model. The five
deformity outcomes observed in this study are all endpoints that are commonly disrupted
by many toxicants in the zebrafish model. Here, the greatest incidence of deformities is
seen at the highest concentrations at all time points, however there was no relationship
between the occurrence of these deformities and disrupted islet development.
Additionally, the lowest concentration (250 nM) did not result in a greater incidence of
morphologic deformities when compared to the controls, but did result in significantly
greater islet areas and an increased incidence of islet deformities, demonstrating the
altered islet development that we are observing is occurring independently of
butylparaben-induced deformities, and that the islet might be a sensitive target tissue of
butylparaben exposure during development.
There was also no clear trend in the occurrence of specific developmental
deformities and deviant islet morphologies. When looking at control, 250 and 3,000 nM
treatments, the relationships between specific developmental deformities and islet
architecture change based on exposure. For example, pericardial edema appeared to occur
independently of islet deformities in the control and 3,000 nM treatment groups (p=
0.650 and p= 0.739 respectively); however there was a lack of independence in this
relationship in the 250 nM treatment group (p= 0.005) (Figure 13). This could be a result
of the different islet deformities that are prevalent at these two different concentrations:
fragmented islets at 250 nM and fuzzy islets at 3,000 nM.
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The time of swimbladder inflation is an endpoint that is commonly disrupted by
toxicants in zebrafish. Here, the highest concentration of butylparaben (3,000 nM)
significantly reduced swim bladder inflation at 4, 5 and 7 days post fertilization.
Exposures to environmental chemicals, such as PCBs have been shown to reduce percent
swim bladder inflation. Jonsson et al (2012) saw a concentration-dependent reduction in
the number of individual zebrafish embryos that exhibited inflated swimbladders at 4
days post fertilization when exposed to 2 nM PCB 126. The swimbladder is derived from
the same endoderm germ layer as the liver, pancreas and the gut. Because the swim
bladder and the intestine are both affected by butylparaben, it may be possible that
butylparaben affects the developing endoderm. Some toxicants, such as TCDD, have
been found to alter both the pancreas and the liver similarly by causing degradation and
necrosis of both organs, which may be due to the endodermal origins of both organs
(Henry et al, 1997 and McCollum et al, 2011). It is also interesting that the transcription
factor for Pdx1 (Foxa2) regulates the development of the foregut that is also derived from
the endoderm, and we are seeing a change in the expression of Pdx1 and not in the
pancreatic hormone index. This could further support the hypothesis that butylparaben
affects the development of the endoderm. Although no apparent liver malformations were
observed in this study, because the liver was not an endpoint that was specifically looked
at, defects may not be detectible by the imaging methods used.
One way to test for this may be to observe the expression of genes that are
required for correct endodermal development such as sox32 (which transcribes for the
transcription factor Sox 32 that has been known to inhibit endodermal formation when
phosphorylated), sqt, cyc and oep (where mutations in these genes have been found to
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lead to failures in endodermal development) as reviewed by Ober et al (2003).
Butylparaben’s effects on endodermal development may also be observed using a Tg(gutGFP) zebrafish line, in which green fluorescent protein expression is restricted to the
endoderm and the organs that it gives rise to. This transgenic line has been used to study
both endodermal and pancreatic development (Field et al, 2003).
It is important to note that all butylparaben concentrations used in these
experiments aim to represent low-dose and environmentally relevant exposures. Although
the exact concentrations of human exposure to butylparaben are still unknown, one study
estimates that human exposures due to long-term cosmetic use in the United States ranges
from 0.26-14.6 mg/day (Masten et al, 2005) (Table 4). Multiple studies have observed
post-exposure concentrations of un-metabolized butylparaben in human urine (0.2-1,240
µg/L), blood (135 µg/L) and amniotic fluid (0.3 µg/L) (Table 4). Because the majority of
butylparaben is metabolized upon exposure, it is likely that these concentrations are
lower than the actual human exposures. In these studies, zebrafish embryos were exposed
to butylparaben concentrations that range from 48.5-582.66 µg/L (250-3,000 nM), and
because these concentrations are within the ranges found in human samples, it is likely
that the concentrations used in these studies are much lower than those of human
exposure.
Table 4. A comparison of pre and post-metabolism butylparaben concentrations
in humans and in the concentrations used in these studies.

Humans

Pre-metabolism Exposure

Post-metabolism measure

260 – 14,600 µg/day

Urine:
0.2-1,240 µg/L
Blood:
135 µg/L
Amniotic Fluid:
0.3 µg/L

(Masten, et al 2005)

Zebrafish

?

48.5-582.6 µg/L
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(Calafat et al, 2010)
(Janjua et al, 2007)
(Philippat et al, 2013)

Although all methods in this study have been performed successfully, there are
limitations to some of the methods. Islets are often occluded by pigmentation at 3 and 4
dpf, which can make it difficult to obtain a clear view of the islet while imaging. Islets
are also often imaged through the yolk sac until 5 dpf and can therefore also become
distorted by the yolk sac contents. An alternative method that could be used to assess
whether butylparaben affects islet development is flow cytometric analysis. Flow
cytometric analysis has been performed to count green fluorescent protein labeled beta
cells from mouse islets (Hara et al, 2003). Flow cytometry would count the exact number
of beta cells in the pancreatic islets, and also observe if exposure to butylparaben is
increasing or decreasing islet area due to changes in the numbers of beta cells. Imaging
with a confocal microscope would also allow for a three-dimensional image of the islet to
be obtained, allowing for more accurate measurements of islet areas.
This study demonstrates the effects of butylparaben on the development of the
pancreatic islet as indicated by an increase in islet area and the incidence of islet
deformities. Butylparaben does not however appear to affect embryonic morphologic
growth, and there was no association between the incidence in morphologic deformities
and islet architecture, suggesting the pancreatic islet may be specifically targeted by
butylparaben. However, it is still unclear whether any of these developmental effects
translate to functional consequences, and future studies are needed to characterize the
long-term effects of these exposures.
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CHAPTER 3
BUTYLPARABEN DISRUPTS REDOX BALANCE IN THE DEVELOPING
EMBRYO
3.1. Introduction
Embryonic development is extremely sensitive to oxidative stress due to changes
in cell proliferation, development and differentiation that take place during this life stage.
Reactive oxygen species (ROS) play an important role in normal embryonic development
by orchestrating cell signal transduction, cell-fate decisions and apoptosis (Ufer et al,
2010). Embryonic exposure to environmental chemicals, such as parabens, can generate
ROS and cause disruptions in cellular redox status (Hansen et al, 2006). Embryonic
oxidative stress can lead to carcinogenesis, cardiovascular dysfunction, pulmonary
diseases, neurodegenerative diseases and diabetes (Wells et al, 2009). Consequently,
antioxidant functions that defend against oxidative stress during embryonic development
are essential.
The most abundant endogenous antioxidant is glutathione (GSH), a tripeptide that
consists of glutamate, cysteine, and glycine. GSH acts as an antioxidant by scavenging
ROS that oxidize the thiol group of the cysteine residue. When GSH is oxidized, it can
dimerize to form glutathione disulfide (GSSG), which can then be recycled back into
GSH by the enzyme glutathione disulfide reductase (Gsr), in a reaction that requires
NADPH (Hansen et al, 2006). The synthesis of GSH involves two ATP-dependent
enzymatic steps. In the rate-limiting first step, glutamate-cysteine ligase (Gcl) catalyzes
the combination of glutamate and cysteine, and next glutathione synthetase (Gss) adds
glycine to the glutamate-cysteine molecule (Timme-Laragy et al, 2013).
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Butylparaben exposure has been found to be linked to the occurrence of oxidative
stress in rodent models (Shah et al, 2012 and Hegazy et al, 2015), and has been
associated with biomarkers of oxidative stress in humans (Kang et al, 2013 and Watkins
et al, 2015). This study aims to analyze whether daily exposure to butylparaben results in
the occurrence of oxidative stress. Studies measured the redox potentials of GSH and
Cysteine, along with total GSH and total Cysteine. Gene expression was also conducted
on the enzymes that are responsible for GSH synthesis (Gclc, Gclm and Gss), and on the
enzyme responsible for recycling oxidized GSSG back into reduced GSH (Gsr). The
expression of two GST enzymes (Gstp and Gsta1) was also measured. These studies aim
to determine whether exposure to butylparaben affects glutathione redox dynamics, and
whether it can be associated with the occurrence of oxidative stress in the developing
zebrafish embryo.
3.2. Materials and Methods
3.2.1. Zebrafish Husbandry
Tg (ins-GFP) embryos were obtained from Dr. Phillip diIorio at the University of
Massachusetts Medical School zebrafish facility (Worchester, MA), and the heterozygous
nrf2afh318 embryos were crossed to obtain the wildtype nrf2a+/+ used in the gene
expression experiments. This genetic line was generated by the Tilling Mutagenesis
Project, obtained from the Moens Laboratory (Fred Hutchinson Cancer Research Center,
Seattle, WA) and was acquired as a generous gift from Dr. Mark Hann of the Woods
Hole Oceanographic Institute (Woods Hole, MA). All zebrafish were maintained as
described above in chapter 2.2.2.
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3.2.2. HPLC Analysis of Soluble Thiols
Embryos were collected from group matings in three 6 liter tanks of an
approximate 1:2 male to female ratio. Embryos were stored at 28.5 ºC and maintained at
low densities (30 embryos per 10 mL) in 0.3x Danieau’s solution and were exposed daily
to 0.01% (v/v) DMSO, 500 or 1,000 nM butylparaben. Embryos were collected at 24 hpf,
or re-exposed to butylparaben at 24 hpf and collected at 28 hpf. All embryos were placed
in 5% PCA buffer and samples were then immediately stored at -80oC. Approximately 60
embryos were used in each treatment.
GSH, Cysteine, GSSG, Cystine, total GSH, total cysteine and the GSH and
cysteine redox potentials (Eh) were measured at the University of Michigan, Ann Arbor,
Michigan by Dr. Karilyn E. Sant using High-performance Liquid Chromatography
(HPLC). As described by Sant et al (2016) a Waters 2695 Allicance Separations module
with a Supelcosi LC-NH2 column was paired with at Waters 2475 Fluorescense Detector
(Sigma, St. Louis MO). Reverse phase chromatography measured GSH, GSSG, cysteine
and cystine. The flow was set to 1 mL/min using mobile phase A (80% methanol) and
mobile phase B (62.5% methanol, 12.5 glacial acetic acid and 214 mg/mL sodium acetate
tryhydrate). Fluorescent detection (excitation 335 nm, emission 518 nm) allowed peaks to
be visualized, which were then processed with a Waters Empower software (Milford,
MA). The Nernst equation VEq=(RT/zF)ln([Xout]/[Xin]) was used to calculate the GSH
and Cysteine redox potentials.
3.2.3. Quantitative real-time PCR
The expression of glutathione-related genes: the catalytic and modifier subunits of
Gcl (gclc and gclm), glutathione synthetase (gss), glutathione disulfide reductase (gsr),
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and two glutathione-s-transferase enzymes (gstp1 and gsta1) were measured using
quantitative real-time PCR with RNA extraction and reverse transcription, which were
performed as described previously in chapter 2.2.8. All primers were first tested for
specificity and efficiency. Primers were designed using Primer-BLAST (NCBI) and were
optimized for melting temperature and for dimerization, to avoid both homodimer and
heterodimer dimerization. Quantitative real-time PCR was also performed as described in
chapter 2.2.9, with β-actin utilized as a housekeeping gene. The primer sequences (5’-3’
orientation) used for the genes gclc, gstp, gsta1 and housekeeping gene β-actin are listed
in Table 5. Primers for gclm, gss, and gsr were purchased from Bio-Rad (PrimePCR™).
Data obtained from qPCR were analyzed using the Bio-Rad CFX Connect Manager™
software, version 3.0 (Bio-Rad). The ddCT method was used to calculate fold change.
Table 5. Primer sequences of glutathione-related genes gclc, gstp, gsta1 and
housekeeping gene β-actin.
Gene
gclc
gstp
gsta1
β-actin

Primer Sequence 5'-3'
Foreword
Reverse
Foreword
Reverse
Foreword
Reverse
Foreword
Reverse

AACCGACACCCAAGATTCAGCACT
CCATCATCCTCTGGAAACACCTCC
CGACTTGAAAGCCACCTGTGTC
CTGTCGTTTTTGCCATATGCAGC
TCACACCTGCCGAAAACAAAG
CCACGAGGAAAGAAGAGTTTGC
CAACAGAGAGAAGATGACACAGATCA
GTCACACCATCACCAGAGTCCATCAC

3.3.4. Statistical Analysis
Data was analyzed using Microsoft Excel and Stata statistical software, version
14.1. All statistical tests were performed by Stata. Two-factorial ANOVAS followed by a
Tukey’s post hoc test or a pairwise t-test were used to test for effects among exposed
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groups and controls. Data are presented as mean and the standard error of the mean
(SEM).
3.3 Results
3.3.1. Analysis of Glutathione and Cysteine Redox Potentials
To analyze redox status in the embryos, GSH, Cysteine, GSSG, Cystine, total
GSH, total cysteine and the GSH and cysteine redox potentials (Eh) were measured using
High-performance Liquid Chromatography (HPLC), with the Nernst equation used to
calculate the GSH and Cysteine redox potentials. There were no significant changes in
the redox status of embryos that were exposed to butylparaben at 3 hpf and were
collected at 24 hpf (Figure 15.B). However, significant changes in redox status were
observed in embryos that were exposed to butylparaben at 3 and 24 hpf and collected at
28 hpf. Butylparaben concentrations of 500 and 1,000 nM increased GSH by 10% and
40%, respectively, and decreased GSSG by 37% and 59%. GSH redox potentials became
more reduced with 500 nM and 1,000 nM butylparaben exposures, decreasing redox
potentials by 7 and 18 mV, respectively. Cysteine redox potentials also became more
reduced, decreasing by 17 and 28 mV (Figure 15.A.). Total GSH and total cysteine did
not significantly change with increasing concentration.
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Figure 15. Redox analysis of glutathione and cysteine at 28 hpf and 24 hpf. A. Redox
analysis of glutathione and cysteine at 28 hpf. Embryonic reduced and oxidized
glutathione (GSH, GSSG) and cysteine were quantified at 28 hpf after exposure to
DMSO, 500 nM or 1,000 nM butylparaben at 3 hpf and 24 hpf. The Nernst equation was
used to calculate cellular redox potentials (Eh). Two factor ANOVAS were used to
determine differences between exposed and control groups followed by a Tukey’s post
hoc test (p<0.05, n= 3 samples of 20 pooled embryos). B. Redox analysis of glutathione
and cysteine at 24 hpf. Embryonic reduced and oxidized glutathione (GSH, GSSG) and
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cysteine were quantified at 24 hpf after exposure to DMSO, 500 nM or 1,000 nM
butylparaben at 3 hpf. The Nernst equation was used to calculate cellular redox potentials
(Eh). Two factor ANOVAS were used to determine differences between exposed and
control groups followed by a Tukey’s post hoc test (p<0.05, n= 1-3 samples of 20 pooled
embryos).

Figure 16. Gene expression of glutathione-related genes. Wildtype embryos were
exposed daily to DMSO, 250, 500 or 3,000 nM butylparaben, and were collected at 78
hpf. Expression of gsta1, gclc, gss and gsr was measured and the ddCt method was used
to calculate fold change, followed by pairwise t-tests to calculate significance (p< 0.05).
N= 5 biological replicates per group with each replicate containing pools of 10-13
embryos.
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3.3.2. Expression of Glutathione-related Genes
The expression of glutathione-related genes was also measured to indicate the
occurrence of oxidative stress. Gene expression of enzymes that are involved in
glutathione synthesis: genes encoding for the two subunits of glutamate-cysteine ligase
(gclc and gclm) and glutathione synthase (gss) were measured in addition to glutathione
disulfide reductase (gsr), that recycles oxidized glutathione (GSSG) back into reduced
glutathione (GSH). The expressions of two genes that encode for glutathione-Stransferases (gstp and gsta1) were also measured. No significant relationship was found
between butylparaben exposure and the expression of gclm. However, gclc, gss and gsta1
were all significantly downregulated at the highest concentration (3,000 nM) whereas gsr
was significantly upregulated at all concentrations in a dose-dependent manner (Figure
16). The expression of gstp was upregulated at the 500 nM concentration (Figure 16).
3.4. Discussion
Oxidative stress occurs when there is an increase in reactive oxygen species
(ROS) and insufficient antioxidant defenses, which often leads to toxic effects such as
damage to lipids, proteins and nucleic acids, contributing to many diseases, including
diabetes. Antioxidants such as glutathione (GSH) and cysteine defend against oxidative
stress by scavenging ROS. However, reactive oxygen species do play important roles in
embryonic development. The redox status, or the ratio of oxidized to reduced
antioxidants, plays a major role in cell signaling and cell fate decisions. More oxidized
redox states often signal cell apoptosis whereas more reduced states lead to cell
proliferation.
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In this study, the redox potentials of the thiol-containing redox couples
glutathione and cysteine were measured in response to butylparaben exposure in 24 hpf
and 28 hpf zebrafish embryos. Significant changes in redox status were only seen in
embryos that underwent an acute exposure before collection (exposed at 24 hpf and
collected at 28 hpf). Embryos that were exposed to butylparaben 4 hours before
collection saw significant changes in both glutathione and cysteine redox potentials
(Figure 15.A.), whereas embryos that were exposed 24 hours before collection saw no
significant changes (Figure 15.B).
Cysteine is regulated independently of GSH and sits at a more reduced state
(Jones et al, 2006). If butylparaben were to cause oxidative stress, it would be expected
that the GSH and cysteine redox potentials would become more oxidized with increasing
butylparaben concentration. However, in this study, reduced glutathione (GSH) and
cysteine increased with increasing butylparaben concentration, while oxidized
glutathione (GSSG) and cystine decreased with increasing concentration, resulting in a
more reduced redox state (Figure 1).
These results contrast somewhat with what has been reported in the literature.
Shah et al (2012) found butylparaben decreased GSH by 43.8% in the liver tissues of rats
that were given 1,320 mg/kg bw/day butylparaben. Hegazy et al (2015) treated rat dams
orally and subcutaneously with 200 mg/kg bw/day butylparaben and measured GSH
dynamics in the brain tissues of the developmentally exposed offspring. Both oral and
subcutaneous butylparaben treatments were found to significantly decrease GSH and the
GSH/GSSG percent ratio, and to significantly increase GSSG and percent oxidized
glutathione, suggesting oxidative stress occurrence in the brain tissues of the offspring.
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None of these studies however observe the effects of butylparaben in the
developing zebrafish model, and butylparaben concentrations used in the animal studies
described above are much higher than the concentrations used in the current study.
Therefore, it is possible that butylparaben causes reductive conditions in the developing
zebrafish, or at lower concentrations, and results in oxidized conditions in mammalian
models or at higher concentrations; or it is possible that we are capturing a rebound
effect. The animal studies that investigate butylparaben and oxidative stress parameters
also only examine specific organs such as liver and brain tissues, whereas this study
analyzes the entire embryo. Therefore, it is possible that butylparaben exposure results in
oxidized conditions in some organs, and reductive conditions in others.
When reductive conditions are detrimental, they are often referred to as “reductive
stress.” Reductive stress is defined as “an abnormal increase in reducing elements” such
as an increased ratio of reduced to oxidized glutathione (Zhang et al, 2010). Reductive
stress may alter cell proliferation and has been found to delay protein folding in yeast,
and can lead to protein aggregation, resulting in cardiomyopathy in mice (Simons et al,
1995 and Zhang et al, 2010). Because the redox results in this study show increased
ratios of reduced to oxidized glutathione and cysteine, it is possible that reductive stress
is occurring here. However, due to the studies that show that butylparaben causes
oxidative stress, it is also possible that the embryos are able to recover and upregulate
antioxidant defenses, in which case we may be missing the window where oxidative
stress occurs. When oxidative stress first occurs due to an accumulation of ROS,
antioxidant defenses are initially slightly depleted and are then turned on in an adaptive
response. As ROS continue to accumulate, antioxidant defenses become depleted and fall
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below baseline in a toxic response (Figure 17). In these studies, increasing GSH with
decreasing GSSG along with the decreased expression of GSH-related genes may
indicate that redox and gene expression were analyzed when embryos were undergoing
an adaptive response.

Figure 17. Increasing levels of reduced glutathione may indicate the occurrence of
an adaptive response.

In order to further explore whether oxidative stress occurs with butylparaben
exposure, the expression of genes that are involved in the synthesis of glutathione were
measured. Glutathione is a tripeptide that is synthesized via two ATP-dependent steps.
The first step is rate-limiting and occurs when the enzyme glutamate–cysteine ligase
(Gcl) combines a glutamate and cysteine molecule. Gcl is composed of a catalytic subunit
(Gclc) and a modifier subunit (Gclm) that is responsible for controlling the rate of GSH
synthesis, and the expression of both subunits have been shown to increase or decrease in
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response to reactive oxygen species (Timme-Laragy et al, 2013, Huang et al, 1993 and
Dickinson et al, 2004). Gclc is responsible for the catalytic activity of Gcl and can be
directly inhibited by GSH, whereas Gclm does not possess any catalytic function but
regulates the activity of Gclc (Dickinson et al, 2004). Oxidative stress is known to
enhance Gcl activity and increase Gcl expression (Franklin et al, 2009). Therefore, if
oxidative stress were to occur, the expression of gclc and gclm would be expected to
increase. The gene expression of both gclc and gclm were measured and showed that only
the expression of gclc was affected by butylparaben exposure. Embryos exposed to the
highest butylparaben concentration (3,000 nM) had significantly decreased expression of
gclc when compared to controls.
During the second step of GSH synthesis, the enzyme glutathione synthase (Gss)
adds a glycine to the glutamate-cysteine molecule. We also measured the expression of
gss and found that its expression was concordant with the expression of gclc, and was
also significantly downregulated with exposure to 3,000 nM butylparaben. The decreased
expression of both gclc and gss suggest decreased activity of both the Gcl and Gss
enzymes. The decreased activity of both Gcl and Gss would likely result in less GSH
synthesis. Piao et al (2011) found that exposure to silver nanoparticles inhibited the
activity of Gclc and Gss in human liver cells, leading to decreased GSH levels and an
increase in ROS. However, because total glutathione was not significantly affected by
butylparaben exposure, this decreased expression cannot be directly translated to
decreased Gcl and Gss enzymatic function. Here, it is unclear whether the reduced
expression of gclc and gss indicate the occurrence of oxidative stress.
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To further investigate whether butylparaben causes oxidative stress in the
developing zebrafish, the expression of glutathione disulfide reductase (Gsr) was also
measured, which is responsible for recycling oxidized GSSG back into reduced GSH in a
NADPH-dependent reaction essential for maintaining GHS levels. We found that the
expression of gsr significantly increased at all concentrations analyzed (250, 500 and
3,000 nM). Redox analysis also showed that GSSG decreased with increasing GSH in a
dose-dependent manner. Because gsr expression was upregulated at concentrations that
were also analyzed for redox status, it is possible that Gsr enzymatic activity is also
increasing. Increased Gsr activity would recycle greater amounts of GSSG back into
GSH, possibly resulting in less GSSG and more GSH. This increase in Gsr activity may
be causing the increased levels of reduced GSH and decreased levels GSSG that are seen
in the redox analysis data. These results also further suggest a reduced environment with
butylparaben exposure, and because gene expression was measured two days after redox
potentials were measured, it appears these reductive effects are lasting.
In contrast to our findings, Shah et al (2011) found butylparaben exposure to
decrease Gsr levels and Gsr activity in a dose-dependent manner in liver tissues of mice,
indicating the occurrence of oxidative stress. The concentrations used by Shah et al
however were much greater than the concentrations used in this study, ranging from
13.33 to 40 mg/0.2mL olive oil/kg bw/day. Therefore, the concentrations used in our
study may not be great enough to decrease Gsr activity or affect its expression.
Additionally, experiments by Shah et al were carried out in mice, which are a different
animal model than the zebrafish model used here, and only the liver tissues of these mice
were analyzed whereas our study analyzes whole embryos. It is possible that Gsr activity
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increases in the liver but decreases in other tissues, an outcome that may be occluded in
our experiments. Experiments performed by Shah et al also analyzed Gsr concentrations
and activity whereas here, only the gene expression of gsr was measured. Because of
these differences it is difficult to compare these two studies.
The mechanism that is causing the upregulation of gsr is still unclear. Unlike the
enzymes that are involved in GSH synthesis, Gsr requires NADPH to recycle GSSG back
into GSH; therefore it is possible that exposure to butylparaben results in the upregulation
of NADPH. The activity of Gsr can be monitored by NADPH consumption, and because
NADPH fluoresces at excitation/emission wavelengths of 340/460 nm (Smith et al,
1988), future studies could analyze whole-embryo NADPH concentrations by measuring
its fluorescence. The pentos phosphate pathway is a major source of NADPH and is a
major source of reducing agents (such as NADPH) for biosynthetic processes and
maintaining redox potentials to protect against oxidative stress (Juhnke et al, 1996).
Therefore it is possible that this pathway is affected by butylparaben exposure, and is
resulting in increased levels of NADPH.
In addition to NADPH, Gsr also requires flavin adenine dinucleotide (FAD) as a
redox cofactor for its activity. FAD has been seen to stimulate Gsr activity in vitro, and
small amounts of 1 µM FAD can activate Gsr within 10 min (Beutler et al, 1969).
Because Gsr is especially sensitive to FAD, it is also possible that exposure to
butylparaben up-regulates or increases FAD in the embryos.
Glutathione also defends against oxidative stress by acting as a cofactor for the
family of enzymes: glutathione-S-transferases (GSTs). This enzyme family is responsible
for the detoxification of many xenobiotics by conjugation to GSH. The conjugated
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xenobiotic metabolites are often more hydrophilic than their unconjugated parent
molecules, and therefore more easily excreted from cells, making them less toxic (Garner
et al, 2012). Three classes of GST enzymes (Alpha, Pi and Mu classes), and 19 GST
genes that are responsible for metabolizing xenobiotics, have been identified in the
zebrafish model (Timme-Laragy et al, 2013). Here, gene expression was analyzed for
gsta1 and gstp1. Similar to the expression of gclc and gss, gsta1 was significantly
downregulated at the 3,000 nM concentration. However, gstp1 was significantly
upregulated at the 500 nM concentration. Shah et al (2011) also found butylparaben
exposure to significantly reduce GST activity in the liver tissues of exposed mice,
suggesting that this reduction in activities of these enzymes may be due to butylparabeninduced protein oxidation. Because butylparaben was also found to cause lipid
peroxidation, the products of lipid peroxidation with these enzymes could modify their
histidine residues, generating protein-protein crosslinked products, reducing their
enzymatic activities (Shah et al, 2011). In this study, the downregulation of Gsta1 is
congruent with the gene expression results and with the redox results that are described
above, suggesting butylparaben exposure results in a more reduced state. However, the
upregulation of Gstp1 suggests a more oxidized state.
This study suggests butylparaben exposure results in a more reduced redox state
in the developing zebrafish. Gene expression of enzymes involved in glutathione
synthesis, the catalytic subunit of Gcl (gclc) and gss were significantly downregulated at
the highest concentration. However, total glutathione was not significantly affected. This
could be because the expression of gclc and gss is downregulated, but the enzymatic
functions are not being affected. Additionally, redox analysis was not performed in

61

embryos that were exposed to the highest concentration (3,000 nM butylparaben). The
expression of gsr, that recycles GSSG back into reduced glutathione (GSH), was
significantly increased at all concentrations, and these concentrations were also analyzed
for redox analysis. Redox data showed that GSSG decreased while GSH increased in a
dose-dependent manner. This could be due to the increased expression of gsr, suggesting
the enzymatic activity of Gsr is increasing with butylparaben exposure. Therefore, it
cannot be concluded whether GSH synthesis is affected by these concentrations of
butylparaben, however, it appears that butylparaben exposure results in a more reduced
redox state. These results do contradict other studies that show butylparaben causes
oxidative stress, though none of these studies use the zebrafish model, and the
concentrations used in other animal studies are much higher than those used in this study.
Although it is still unclear whether exposure to butylparaben causes reductive or
oxidative stress, the data from this study indicate that exposure to butylparaben perturbs
the redox status in the developing embryo. Future studies need to be conducted to further
determine whether butylparaben causes oxidative stress in the developing zebrafish.
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CHAPTER 4
CONCLUSIONS
These studies reveal that embryonic exposures to butylparaben affect pancreatic
development in the zebrafish model, however, there is not enough evidence to conclude
whether oxidative stress is involved. Exposure to butylparaben results in increased islet
area, and an increased incidence in islet deformities while not significantly affecting
embryonic gross development. There is also no apparent association between
morphological deformities and islet architecture, suggesting the islet may be especially
sensitive to butylparaben as noted earlier. Butylparaben also appears to create a more
reduced redox environment. Reduced GSH and cystine increase with decreasing oxidized
GSSG and cysteine in a dose-dependent manner, and both glutathione and cystine redox
potentials become more reduced with increasing concentration. This could indicate
increased enzymatic activity of Gsr, that is responsible for recycling GSSG back into
GSH. The gene expression of the enzymes involved in the synthesis of glutathione (gclc
and gss) are significantly downregulated at the highest concentration, however total
glutathione is not significantly affected by butylparaben, suggesting the activity of these
enzymes may not be changed. The increasing reduced glutathione with increasing
butylparaben concentration, along with the down-regulation of glutathione-related genes
may indicate that embryos were analyzed while undergoing an adaptive response to
oxidative stress.
It is still unclear whether oxidative stress is the mechanism that is driving the
development of these deviant islet morphologies, and it is possible that another
mechanism is contributing to this such as PPARγ activation. Butylparaben has been seen
to activate PPARγ, resulting in increased adipocyte differentiation. Although it is unclear
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what is contributing to the increased islet areas observed in these studies, PPARγactivated beta cell differentiation may potentially play a role.
To further investigate whether butylparaben induces oxidative or reductive stress,
and whether this stress may impact the developing islet, future studies will analyze
pancreas development with antioxidant N-acetylcysteine (NAC) and pro-oxidant tertbutyl hydroperoxide co-treatments. RNA sequencing also needs to be performed in order
to determine whether other oxidative stress related genes are being affected along with
other genes that are involved in pancreatic development.
It is still unclear whether these islet deformities will develop into functional
consequences, or if embryos are able to recover once the chemical exposure has been
removed. Further studies are needed in adult zebrafish that were exposed to butylparaben
as embryos, to see whether these islet deformities lead to insulin resistance later in life,
and potentially the development of diabetes. The zebrafish is an ideal model to test for
this because the diabetic zebrafish displays known secondary complications that are
associated with diabetes in humans such as neuropathy, and impaired wound healing,
which can be measured by caudal fin regeneration (Intine et al, 2013). Additionally, the
zebrafish can regenerate its damaged pancreas and restore it to a similar state that would
be expected in a post-transplant human patient (Intine et al, 2013). Analysis of glucose
homeostasis can also be performed in adult zebrafish via blood analysis.
However, very little is still known about the impact of environmental toxicant
exposures on the developing pancreas and how oxidative stress impacts development.
The results from these studies aim to contribute to the understanding of how exposure to
an environmental toxicant, butylparaben, affects the developing pancreas. Future studies
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are needed to investigate and whether oxidative stress is a mechanism that may impact
the pancreas and lead to the development of disease, specifically diabetes, later in life.
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